SCHEMBL1016003

SCHEMBL1016003

COC(=O)c1cc(Cl)ccc1NC(=O)COCC(=O)Nc1ccccc1-c1ccncc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 8/20 0.47
KDM4E B2RXH2 2/20 0.47
NPSR1 Q6W5P4 2/20 0.47
SMN1; SMN2 Q16637 2/20 0.45
GAA P10253 1/20 0.45
CYP1A2 P05177 1/20 0.45
CYP3A4 P08684 1/20 0.45
CYP2C9 P11712 1/20 0.45
CYP2C19 P33261 1/20 0.45
SLC6A4 P31645 1/20 0.45
SLC6A3 Q01959 1/20 0.45
SERPINE1 P05121 1/20 0.45
LMNA P02545 1/20 0.45
HSD17B10 Q99714 2/20 0.45
KMT2A Q03164 3/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
BDKRB1 P46663 1/20 0.44
MAPT P10636 2/20 0.44
TSHR P16473 1/20 0.44
MAPK10 P53779 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1015633 0.89 SERPINE1 (0.56) ALDH1A1KDM4ENPSR1SMN1; SMN2GAA
Hydrochloric Acid SCHEMBL1016123 0.88 SERPINE1 (0.55) ALDH1A1KDM4ENPSR1SMN1; SMN2GAA
SCHEMBL1015136 0.88 SLC6A4 (0.51) ALDH1A1KDM4ENPSR1SMN1; SMN2GAA
SCHEMBL1014545 0.86 KDM4E (0.46) ALDH1A1KDM4ESMN1; SMN2GAACYP1A2
SCHEMBL1015635 0.85 CNR1 (0.51) KDM4ESMN1; SMN2GAASERPINE1KMT2A
SCHEMBL1015370 0.80 KDM4E (0.60) ALDH1A1KDM4ESMN1; SMN2GAACYP1A2
SCHEMBL1794335 0.79 SMN1; SMN2 (0.69) ALDH1A1KDM4ESMN1; SMN2GAACYP1A2
SCHEMBL1797516 0.79 ALDH1A1 (0.50) ALDH1A1KDM4ESMN1; SMN2GAACYP1A2
SCHEMBL7125633 0.78 ALDH1A1 (0.62) ALDH1A1KDM4ESMN1; SMN2GAACYP1A2
SCHEMBL1013966 0.78 L3MBTL1 (0.60) ALDH1A1KDM4ENPSR1SMN1; SMN2GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8415479-B2 Inhibitor of plasminogen activator inhibitor-1 RENASCIENCE CO., LTD. (JP) 2013-04-09 US disclosed
US-20110112140-A1 INHIBITOR OF PLASMINOGEN ACTIVATOR INHIBITOR-1 RENASCIENCE CO., LTD. (JP) 2011-05-12 US disclosed
EP-2272822-A1 INHIBITOR OF PLASMINOGEN ACTIVATOR INHIBITOR-1 Renascience CO., LTD. (JP) 2011-01-12 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110112140-A1 INHIBITOR OF PLASMINOGEN ACTIVATOR INHIBITOR-1 SERPINE1, SERPINB1, SERPINC1 ALDH1A1 888/4885KDM4E 4108/4885NPSR1 3372/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.